Market Cap
$45.05 Billion
USD as of July 1, 2025
| Company | Market Cap (USD) |
|---|---|
Abbott
|
$233.33 B |
Boston Scientific Corporation
|
$154.34 B |
Stryker
|
$151.06 B |
Medtronic
|
$113.25 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd
|
$37.52 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Edwards Lifesciences Corporation is a medical technology company specialized in artificial heart valves and hemodynamic monitoring. Edwards Lifesciences designs, manufactures, and markets surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care catheters.
United States
languages
Healthcare
languages
Medical Devices
United States Healthcare
United States Medical Devices
Edwards Lifesciences Corporation has the following listings and related stock indices.
Stock: NYSE: EW
Stock: BMV: EW
Stock: Bovespa: E1WL34
Stock: FSX: EWL
Stock: XETR: EWL
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.